Scientific American’s Worldview 2011 Preview

Scientific American will release the third annual Worldview: A Global Biotechnology Perspective at this year’s BIO International Convention.

BIO Urges U.S. Trade Representative to Preserve IP Protection Abroad

The Biotechnology Industry Organization (BIO) stresses the critical importance of protecting intellectual property abroad in comments recently filed with the U.S. Trade Representative (USTR) on the 2011 Special 301 Review.

2011 Special 301: BIO Comments to USTR

In comments to the U.S. Trade Representative (USTR), BIO stresses the critical importance of protecting intellectual property abroad and made recommendations about which countries to include on the Priority Watch and Watch List, which to elevate as a Priority Foreigh Country, and which countries to monitor.

Intellectual Property in Emerging Markets

Brenda Herschbach Jarrell and Jennifer Groves present an overview of the IP landscape in China, India, Brazil and Korea.

BIO comments on the proposed accession of Malaysia to the Trans Pacific Partnership (TPP) negotiations

Parties to the TPP negotiation are a mixture of countries that actively cultivate and import GE crops, as well as those that have yet to develop functioning regulatory systems. Therefore, the TPP offers the potential to achieve a common regulatory approach and disciplines for agricultural biotechnology.

Biological Diversity: Draft Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from Their Utilization to the Convention on Biological Diversity

The Heads of Biotechnology Associations: Asia, Europe and the Americas and their members support the agreed objective of the Protocol and the greater goal to establish a practical and workable international regime governing access to genetic resources and the fair and equitable sharing of benefits arising from these resources.

Intellectual Property: Compulsory Licenses Published by the Department of Industrial Policy and Promotion within India's Ministry of Commerce and Industry

BIO is disappointed to see the recent DIPP’s discussion paper on compulsory licensing of biopharmaceuticals, which sends a deeply troubling message to investors and collaborators at a time when the industry and the Government of India are seeking to increase investment, collaboration, and innovation in the biotech sector.

International: National Export Initiative

Biotechnology companies would be less likely to export their products into countries that do not provide meaningful IP and data protections

BIO Applauds Administration’s Progress in Brazilian Cotton Dispute

The Obama Administration has made substantial progress to avoid retaliatory measures in a long-running “cotton dispute” brought by Brazil against the United States.

BIO Welcomes EU Decision on Biotech Crops

The Biotechnology Industry Organization (BIO) applauded today’s announcement by the European Commission to authorize the cultivation of a biotech potato, as well as the commercialization of three varieties of biotech maize for food and feed uses and import and processing.